#Hong Kong #financial results #digital health #CIMG Inc.

CIMG Inc. Reports Impressive Q1 Financial Results

CIMG Inc., a prominent player in the digital health and sales development space, has announced remarkable financial results for the first quarter ending December 31, 2025. This report reflects the company’s ongoing expansion into new business sectors, notably medicine-food homology products and computing power solutions.

Financial Performance Overview

For the three months concluded on December 31, 2025, CIMG Inc. revealed a total revenue of $15,768,796, a significant increase from just $22,853 in the same quarter last year. This surge in revenue underscores the initial impacts of the company's strategic diversification into innovative health products and advanced technological solutions. The notable growth is attributed to the early commercialization stages of their newly introduced business lines.

In addition to revenue growth, CIMG has successfully expanded its digital asset holdings. By the end of December 2025, the company reported holding 730 Bitcoins, valued at $63,978,821. This development signifies a robust approach towards integrating cryptocurrency into their operational strategy.

The book value per share stands at approximately $3.6, reflecting a solid foundation for potential investors and stakeholders.

Strategic Business Transformation

CIMG’s strategic shift towards health consumer goods and computing technology has seen significant progress. The company has made key advancements in several areas:

1. Product Line Expansion: Leveraging innovative digital marketing strategies, CIMG has witnessed substantial sales growth in its medicine-food homology product lines. The computing power product series launched in September 2025, is now catering to enterprise clients, offering advanced GPU hardware integrated with AI data processing modules. Several contracts have been signed, including notable partnerships with major firms like China Merchants Bank.

2. Global Subsidiary Growth: The company has accelerated its international expansion by establishing wholly-owned subsidiaries in Shenzhen and Foshan, China, which enhance its production and research capabilities across Asia. They have also acquired Braincon Limited and its subsidiary, marking a significant reinforcement of CIMG’s operational framework in the region.

Future Directions and Goals

Alice Wang, the Chairman and CEO of CIMG, emphasized the company’s commitment to focusing on the Asian market. Their dual focus strategy on health consumer goods and computing power products will guide future operational decisions. The company plans to optimize pricing strategies, enhance product margins, and expand both online and offline distribution channels, particularly for their maca series and other homology products.

Furthermore, CIMG intends to increase research and development investments in computing products, aiming to expand their enterprise customer base and boost revenue from this segment.

On the financial management side, CIMG is focused on improving its capital structure while adhering to Nasdaq listing standards, which includes rectifying previous compliance issues and appealing against any delisting decisions. Wang also noted the necessity to enhance internal controls and operational efficiencies, ultimately steering the company towards profitable growth.

About CIMG Inc.

CIMG Inc. is at the forefront of digital health and sales development, adeptly leveraging AI and cryptocurrency to foster business innovation and growth. The company aims to empower its clients to maximize user engagement and enhance brand value. Their current clientele includes prominent brands such as Kangduoyuan, Maca-Noni, Qianmao, Huomao, and Coco-mango.

CIMG’s forward-looking stance includes a commitment to transparency and integrity, poised to navigate through market fluctuations while retaining focus on sustainable growth and compliance.

Forward-Looking Statements

As with any strategic forecasts, CIMG acknowledges the inherent risks and uncertainties. The company underscores its proactive measures to adapt to market conditions while pursuing its outlined goals and objectives with diligence and integrity.